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Direct comparison of distinct naive pluripotent
states in human embryonic stem cells
S. Warrier1, M. Van der Jeught1, G. Duggal1,2, L. Tilleman3, E. Sutherland1, J. Taelman1, M. Popovic1, S. Lierman1,
S. Chuva De Sousa Lopes1,4, A. Van Soom5, L. Peelman6, F. Van Nieuwerburgh3, D.I.M. De Coninck3, B. Menten7,
P. Mestdagh7, J. Van de Sompele7, D. Deforce3, P. De Sutter1 & B. Heindryckx1
Until recently, human embryonic stem cells (hESCs) were shown to exist in a state of primed
pluripotency, while mouse embryonic stem cells (mESCs) display a naive or primed
pluripotent state. Here we show the rapid conversion of in-house-derived primed hESCs on
mouse embryonic feeder layer (MEF) to a naive state within 5–6 days in naive conversion
media (NCM-MEF), 6–10 days in naive human stem cell media (NHSM-MEF) and 14–20 days
using the reverse-toggle protocol (RT-MEF). We further observe enhanced unbiased
lineage-speciﬁc differentiation potential of naive hESCs converted in NCM-MEF, however,
all naive hESCs fail to differentiate towards functional cell types. RNA-seq analysis reveals a
divergent role of PI3K/AKT/mTORC signalling, speciﬁcally of the mTORC2 subunit, in the
different naive hESCs. Overall, we demonstrate a direct evaluation of several naive culture
conditions performed in the same laboratory, thereby contributing to an unbiased, more
in-depth understanding of different naive hESCs.
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A
lthough both originate from the inner cell mass of
pre-implantation blastocysts1,2, mouse embryonic stem
cells (mESCs) and human ESCs (hESCs) exhibit
distinctive characteristics. Human ESCs display a primed state
of pluripotency, similar to mouse epiblast stem cells (EpiSCs)3,4
derived from the post-implantation epiblast. Primed hESCs
display ﬂat colony morphology, low single-cell clonogenicity,
dependence on TGFb/activin/nodal signalling and show
inefﬁciency to contribute to chimeras. Conversely, mESCs
reside in the so-called naive pluripotent state, characterized by
domed colonies, increased single-cell survival, dependence on
JAK/STAT signalling and efﬁcient contribution to chimeras5–7.
Their high single-cell clonogenicity facilitates bulk culture,
deeming them more favourable for future practical applications.
Moreover, naive mESCs are also more homogeneous, leading to
unbiased and efﬁcient directed differentiation towards germ layer
derivatives8,9. Recently, several groups have formulated protocols
to induce naive pluripotency in hESC, both from pre-existing
primed hESCs and by direct derivation from the blastocyst stage.
This has been achieved using naive human stem cell media
(NHSM)10, the reverse-toggle (RT) protocol11, 5i/L/F/A
medium12 or by ‘resetting’ primed hESCs, via ectopic NANOG
and KLF2 expression, followed by exposure to naive culture
medium without bFGF13. Likewise, our group recently
formulated a novel naive conversion medium (NCM) that
facilitates the induction of naive pluripotency from primed
hESCs, as well as the derivation of naive mESCs from the
blastocyst stage8. To date, efforts to compare naive hESC induced
via different culture conditions have primarily been performed
using published data sets from several groups, which may
introduce bias due to the use of different stem cell lines in
different laboratories and different transcriptomic platforms
employed. Takashima et al.13 hybridized their reset cells on a
similar microarray platform as NHSM-naive hESCs and
compared their biological results with published data sets for
NHSM and 3iL-naive hESCs. Lineage-speciﬁc markers, such as
AFP and EOMES were expressed in NHSM and 3iL-naive hESCs,
while chromatin modiﬁers were downregulated compared to
reset cells13. Whether these ﬁndings are truly biologically
representative is speculative as only the reset cells were induced
in culture, while the analysis of NHSM and 3iL-naive hESCs
exclusively relied on published data sets from other studies. In
addition, several differences were observed between the different
lines converted in NHSM conditions13. Further, detailed
comparative computational analysis of naive and primed
states14 also suggested that the resulting differentially expressed
genes are taken as a proxy of the target protein, which may lead to
false positive and false negative results14. Therefore, to achieve
more comprehensive and reliable biological conclusions,
performing experiments in parallel within the same laboratory
and on identical hESC lines, rather than solely relying on data set
analysis, is imperative. An alternative study performed weighted
gene co-expression network analysis on various naive data sets15
and suggested a potential overlap between reset cells and
5iL/F/A-naive hESCs with minor overlap with primed hESCs.
However, the authors stress for caution in data interpretation,
as the variations in culture conditions result in transcriptomic
noise. Therefore, in order to accurately evaluate biological
differences, culture conditions require standardization, while the
transcriptomic sample numbers need to be increased15. Hence,
we report, a detailed comparative analysis of naive hESCs
converted in distinct naive media conditions in the same
laboratory to provide a more unbiased approach to study the
underlying variances between these differentially converted naive
hESCs. Since all naive culture conditions to convert primed state
hESCs towards a naive pluripotent state used mouse embryonic
ﬁbroblast (MEFs) as feeder layer, we have denoted the three
conditions as NCM-MEF, NHSM-MEF and RT-MEF below.
We report efﬁcient conversion of three in-house-derived primed
hESCs towards a naive pluripotent state, speciﬁcally in
NCM-MEF and NHSM-MEF media. We also demonstrate that
the naive hESCs exhibit dependence on mTORC2 subunit of
PI3K/AKT/mTORC pathway, are unique transcriptomically to
their parental primed counterparts and can differentiate
efﬁciently towards lineage-speciﬁc progenitors.
Results
Enhanced naive state displayed by NCM/NHSM-MEF naive
hESCs. To study the characteristics and properties of differen-
tially induced naive hESCs in a controlled setting, we converted
existing, in-house-derived three primed hESC lines, within the
same laboratory, in different culture conditions. These included
NHSM, RT and the NCM protocol. We speciﬁcally selected these
protocols, as they were shown to generate karyotypically normal
naive hESCs, without the need for gene transfection. We also
selected conversion on MEF feeder layer considering only NHSM
culture medium is thus far capable of supporting feeder-free
culture of naive hESC. Hence, to avoid bias, we utilized standard
naive culture conditions on MEF feeder layer for all three naive
media for downstream comparative analysis, similar to primed
hESC culture conditions.10. Although, secondary optimization
also revealed PKCi and ROCKi as optional boosters for NHSM-
naive hESCs condition10 and ROCKi for NCM8, we only selected
the initial core components of each media for the comparative
analysis on MEF feeder layer. The naive hESC lines induced in 5i/
L/F/A medium were shown to be karyotypically abnormal and
exhibited irreversible loss of imprinting12,16, which is concerning
as their inability of methylation memory inheritance can
inﬂuence differentiation capacity for future therapeutic
applications. As well, the ‘reset cells’ require ectopic expression
of NANOG and KLF2, prior to culture in naive culture medium,
and thus, these naive culture conditions were excluded from this
study13.
Upon exposing the in-house-derived primed hESC lines in
NCM-MEF, NHSM-MEF and RT-MEF conditions (Fig. 1a),
we observed successful conversion towards a more naive state in
all three conditions, with the ﬁrst evidence depicted by the
appearance of domed-like colony morphology (Fig. 1b).
These mouse-like naive colonies appeared within 5–6 days in
NCM-MEF, 6–10 days in NHSM-MEF and 14–20 days in
RT-MEF naive media. NCM-MEF cells manifested a faster
doubling time (12–18 h) compared to NHSM-MEF (14–19 h) and
RT-MEF (22–24 h; Fig. 2a, Supplementary Figs 1 and 2).
Similarly, NCM-MEF and NHSM-MEF naive hESC lines
demonstrated high single-cell survival (95%), whereas RT-MEF
naive hESC lines showed a lower efﬁciency of 77%. Nonetheless,
the doubling time and single-cell clonogenicity of the cells
converted in all naive media continued to be signiﬁcantly variable
(Po0.05) compared to their primed counterparts, with primed
hESC lines exhibiting increased doubling time of 47–52 h and
decreased single-cell clonogenicity of only 25% (Fig. 2a,
Supplementary Figs 1 and 2). Next, all primed hESCs and their
NCM-MEF naive counterparts exhibited a normal chromosomal
proﬁle as veriﬁed by array comparative genome hybridization,
however, in NHSM-MEF and RT-MEF naive hESC culture
conditions, only UGent11-70 and UGent11-60/UGent11-70 naive
hESCs were karyotypically normal, respectively (Fig. 2b,
Supplementary Figs 1 and 2). Converted naive hESCs were
positive for OCT4/NANOG (Fig. 2c, Supplementary Figs 1 and 2)
and spontaneously differentiated into all the three germ layers
(Fig. 2d, Supplementary Figs 1 and 2). Interestingly, embryoid
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bodies (EBs) derived from NCM-MEF naive hESCs showed a
consistent differentiation efﬁciency towards ectoderm (NESTIN),
mesoderm (HAND1) and endoderm (AFP, GATA4, GATA6). EBs
from NHSM-MEF naive hESCs expressed lower levels of HAND1
and those from RT-MEF naive hESCs showed decreased
expression of both NESTIN and HAND1 (Fig. 2d).
Naive hESCs rely on mTORC2 subunit to maintain pluripotency.
We further conﬁrmed naive pluripotency by quantitative real-
time PCR (qRT-PCR) gene expression analysis on the three naive
hESC lines and their primed counterparts. Signiﬁcantly increased
KLF2 (n¼ 3, Po0.05) expression was observed in NCM-MEF
naive hESCs, while KLF4 (n¼ 3, Po0.05) was expressed higher
in NHSM-MEF naive hESCs. RT-MEF naive hESCs showed
reduced expression of these markers, similar to primed hESCs.
OCT4 expression was consistent in all hESC lines (Fig. 2e). The
naive marker REX1 was highly expressed in all naive hESC lines
compared to primed (n¼ 3, Po0.05), however, lower expression
observed in RT-MEF naive hESC lines compared to NCM- and
NHSM-MEF naive hESC lines (Fig. 2e, Supplementary Figs 1
and 2).
We observed a signiﬁcant upregulation of naive markers
including KLF2 (6–10-fold), PRDM14 (5–40-fold) and TCL1B
(60–80-fold) in hESCs converted in the NCM-MEF protocol
compared to NHSM- and the RT-MEF protocol (n¼ 3, Po0.05,
Fig. 2e, Supplementary Figs 1 and 2). This suggests that in NCM-
MEF naive hESCs, KLF2 and PRDM14 (a PR-domain-containing
transcriptional regulator), both known to work synergistically to
facilitate the reprogramming of EpiSCs towards a naive mESC-
like state of pluripotency17–20 have a similar role in inducing
naive pluripotency in hESCs. Interestingly, NHSM-MEF naive
hESCs continued to show signiﬁcantly increased expression of
ESRRB (n¼ 3, Po0.05) compared to NCM- and RT-MEF naive
hESCs (Fig. 2e, Supplementary Figs 1 and 2). This correlates with
their elevated KLF4 expression level (Fig. 2e Supplementary Figs 1
and 2), as ESRRB is a direct target of KLF4, as seen in mESCs
both also being downstream targets of NANOG (refs 21,22). The
activation of the LIFRb/gp130 receptor by LIF can activate the
PI3K pathway, which acts on the serine/threonine protein kinase
B (PKB or AKT) downstream effectors23. TCL1B is known to
enhance the AKT kinase activity and induce naive pluripotency24.
This is further facilitated by PRDM14, which inhibits FGF
signalling and activates AKT-mTORC signalling17–19. This was
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Figure 1 | Conversion of primed hESCs towards a naive state in different naive media combinations. (a) Overview of small molecules and growth
factors supplemented in NCM, NHSM and RT naive media. (b) Morphological analysis of hESC cultures in different naive media and their transition
from primed pluripotency-speciﬁc ﬂat morphology towards dome-shaped undifferentiated naive colonies. NCM and NHSM media comprised of several
domed colonies whereas their frequency was lower in RT media. Scale bars, 200mm.
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further conﬁrmed upon exposing primed, NCM-MEF, NHSM-
MEF, RT-MEF naive hESCs to rapamycin (mTORC1 inhibitor)25
and PP242 (mTORC1/2 inhibitor)26 (Supplementary Fig. 3).
Compared to primed hESCs, all naive hESCs exhibited
increased apoptosis in response to rapamycin treatment, which
increased in PP242 condition (Supplementary Fig. 3). Similarly,
NANOG expression was almost absent in PP242-treated naive
hESCs whereas rapamycin-treated naive hESCs showed marked
downregulation in NANOG levels (Supplementary Fig. 3). Hence,
as naive hESCs express increased levels of PRDM14 and TCL1B in
contrast to primed hESCs, albeit at varying levels, and undergo
apoptosis upon exposure to mTORC inhibitors (especially
mTORC2 inhibitor), our results suggest an intriguing role of
the PI3K/AKT/mTORC-signalling pathway in facilitating the
naive state in hESCs. This is supported by the knowledge that the
self-renewal of naive mESCs is dependent on PI3K/AKT,
LIF/STAT3, BMP/SMAD signalling which work together
to inhibit primed pluripotency-associated ERK and GSK3b
pathways, thereby allowing Nanog and c-Myc to maintain
pluripotency27,28. Importance of mTORC has been highlighted
in naive mESCs and mouse embryos whereby, disruption of
mTORC resulted in their reduced cell size as well as impaired
proliferation29. High levels of bFGF also activate the PI3K/AKT/
mTOR pathway, leading to the inhibition of MAPK/ERK (MEK)
signalling essential for the naive pluripotent state while low FGF
continues to activate the MEK pathway30. Hence, increased
concentration of bFGF (8-12 ngml 1) in all naive media directly
relates to the upregulation of PI3K/AKT/mTOR and suppression
of the MEK pathway in naive hESCs. This is contrary to the
primed state, in which MEK signalling is maintained via
PI3K/AKT signalling, due to the lower FGF concentration
(4 ngml 1)31. To date, only one group has established naive
hESCs in the absence of bFGF13, hence the role of bFGF in the
establishment and maintenance of naive hESC remains to be
elucidated.
Naive hESCs differentiate robustly towards immature cell types.
Further, we aimed to study the lineage-speciﬁc differentiation
potential of naive hESCs. Upon exposing the EBs derived
from NCM-, NHSM- and RT-MEF naive hESCs to ectodermal
differentiation cues, we observed high upregulation of NESTIN
and PAX6, by 8- and 6-fold (n¼ 3, Po0.05) in NCM and
NHSM-EBs, respectively, compared to RT-EBs and their primed
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Figure 2 | Assessment of naive pluripotency in the newly formed naive hESCs from primed hESC line UGent11-70. (a) Doubling time and single-cell
clonogenicity assays for primed hESCs, NCM-, NHSM- and RT-naive hESCs. a* compared to a and b* compared to b, *Po0.05. (b) Depiction of
chromosomal analysis for primed hESCs, NCM-, NHSM- and RT-naive hESCs via array comparative genome hybridization (aCGH). (c) Representative
immunoﬂuorescence image for pluripotency makers OCT4 and NANOG in NCM-, NHSM- and RT-naive hESCs; Scale bars, 200mm. (d) qRT-PCR analysis
for ectoderm, mesoderm and endoderm markers on spontaneously differentiated primed hESCs, NCM-, NHSM- and RT-naive hESCs as EBs for 14 days.
(e) Gene expression analysis for naive-pluripotency speciﬁc genes on undifferentiated primed hESCs, NCM-, NHSM- and RT-naive hESCs. a* compared to a
and b* compared to b, *Po0.05. The data are represented as mean±s.d.
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counterparts (Fig. 3a, Supplementary Figs 4 and 5). We observed
no expression of mesodermal or endodermal markers in all
naive-EBs, whereas EBs from primed hESCs continued to express
markers of all lineages, albeit at low levels. This indicates that
naive hESCs are transcriptionally more homogenous, similar to
mESCs7,9. When subjected to mesoderm-directed differentiation,
NCM-EBs exhibited highly efﬁcient differentiation, with HAND1
signiﬁcantly upregulated by 10-fold (n¼ 3, Po0.05) compared to
NHSM-EBs, which showed lower potential to differentiate
towards mesoderm and continued to express ectoderm genes.
RT-EBs also exhibited efﬁcient mesoderm differentiation,
as depicted by a 2 to 8-fold increase in HAND1 expression
compared to NHSM-EBs and primed-EBS (Fig. 3b,
Supplementary Figs 4 and 5). Finally, NCM-EBs, NHSM-EBs
and RT-EBs underwent robust endoderm-directed differentiation
indicated by increase in AFP and GATA6 expression levels (n¼ 3,
Po0.05), while primed hESC-EBs continued to express ecto and
mesodermal markers (Fig. 3c, Supplementary Figs 4 and 5).
To study the functional capacity of these converted naive hESCs
compared to their primed origins, we induced neuronal32 and
cardiac differentiation33 using well-established protocols for
hESC. Differentiation towards the neuronal lineage facilitated
the induction of neuronal rosettes for all conditions, although
only primed hESCs formed well-characterized and recognizable
neuronal processes (Supplementary Fig. 6a). For cardiac
differentiation, spontaneously beating population of cells were
only observed in cells differentiated from primed hESCs
(Supplementary Fig. 6b). Although both naive and primed
hESCs expressed early neuronal marker PAX6 and cardiac
progenitor markers NKX2.5/GATA4 (Supplementary Figs 7,8),
only differentiated primed hESCs (and to some extent RT-naive
hESCs) expressed the mature neuronal markers b-TUBULIN
and TROPONIN/MYOSIN for mature cardiac lineage (Fig. 4).
This supports the absence of spontaneously beating clusters in
cardiomyocytes differentiated from naive hESCs, in contrast to
primed hESC where beating clusters were observed.
Overall, although we see upregulation of lineage-speciﬁc
markers for naive hESCs, their ability to undergo terminal
differentiation towards functional cell types is limited compared
to primed hESCs in the current setting. Similar to germ cell
differentiation from hESCs34, priming of the naive cells to an
epiblast-like pluripotency state maybe required. However, further
studies are warranted to test whether this epiblast-like state is the
equivalent or better than the primed counterpart. It also has to be
taken into account that currently used differentiation protocols
have been optimized using primed hESC, which mostly differ
from the protocols used for directed differentiation in mESC.
Hence, these results suggest that the current well-established
differentiation protocols for primed hESCs need optimization
when applied to naive hESCs to obtain mature cell types.
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Figure 3 | Germ-layer speciﬁc differentiation of naive hESC line UGent11-70. Gene expression analysis for lineage-speciﬁc genes upon directed
differentiation of naive hESC line UGent11-70 towards (a) ectoderm, (b) mesoderm and (c) endoderm. All germ layer markers were analysed irrespective of
the targeted lineage to determine the heterogeneity in differentiation between the different naive medium conditions as well as between primed and naive
conditions. Dashed box represents the gene expression for markers speciﬁc for that lineage. The data are represented as mean±s.d.
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Naive hESCs exhibit unique transcriptional proﬁle. Naive
pluripotency-associated transcriptomic reconﬁguration was
determined using RNA-seq by comparing multiple and inde-
pendent cultures of three primed hESC lines and their naive
counterparts. A ﬁrst principal component analysis (PCA) on
normalized data showed that the primed cells separated from the
converted naive hESC cells (Fig. 5a, Supplementary Data 1).
Statistical differential expression analysis comparing primed
hESC (selected as the control group) to all the naive converted
cells revealed that B1,638 genes (false discovery rate
(FDR)o0.05) were differentially expressed between the naive and
primed hESCs. PCA and clustering analysis based on the differ-
entially expressed genes separated all naive hESCs cultured in
NCM-, NHSM- and RT-MEF naive media and exhibited a unique
transcriptome compared to primed hESCs (Fig. 5b,c,
Supplementary Data 2). GO analysis showed enrichment for
terms related to RNA processing, DNA replication and repair,
regulation of cell cycle process and downregulation of terms
related to extra cellular adhesion and various developmental
processes (Supplementary Data 3,4). Differential KEGG pathway
analysis showed upregulation of pathways related to oxidative
phosphorylation, cell cycle regulation whereas pathways related
to differentiation were downregulated in the naive hESC
(Supplementary Data 5). During human embryo development,
there is an increase in dependence on oxidative phosphorylation
as glucose can negatively affect early embryogenesis, and the
pre-implantation blastocyst relies on this metabolic state
facilitated by mitochondrial biogenesis and maturation35. Hence,
the dependence of naive hESCs on oxidative phosphorylation
instead of glycolytic metabolism, similar to human pre-
implantation epiblast, is an important hallmark indicative of
their naive state35–37. Next, to understand the differences between
primed parental hESCs and the individual naive conversion
conditions, differential expression was analysed between the
primed hESC and the individual treatment groups. This analysis
revealed 2,019, 1,996 and 2,007 genes to be differentially
expressed when NCM, NHSM and RT conditions were
individually compared to the primed condition, respectively
(Supplementary Data 6–8). Gene set enrichment analysis showed
upregulation of categories related to embryonic stem cell core and
stemness in all naive hESCs. Interestingly, categories related to
mitochondria, MYC targets and TGFb were upregulated in NCM
and NHSM conditions only (Supplementary Data 9–11).
In-depth dissection of the data for a subset of key genes
required for acquisition of naive pluripotency led to interesting
observations. AKT1 (also known as protein kinase B), is required
by the PI3K/AKT pathway to facilitate cell-cell signalling
via insulin-like growth factor, which leads to activation of the
mTOR and inhibition of the GSK3b pathway24. We observed
upregulation of AKT1 in the naive hESCs (speciﬁcally in NCM-
MEF, n¼ 3, Po0.05), while it continued to be lowly expressed in
the primed and NHSM-MEF naive hESCs (Fig. 6a). Increased
AKT1 phosphorylation is facilitated by the mTORC2 subunit,
hence promoting cell proliferation and growth. PTEN, required in
maintaining the negative feedback loop mechanism in PI3K/AKT
pathway was expressed in all hESCs38. RICTOR and MAPKAP1,
known genes exclusive to mTORC2 subunit39 showed increased
expression compared to DEPTOR, a common subunit between
mTORC1 and mTORC2 subunits, in the naive lines. Although
primed hESCs exhibited a similar expression proﬁle for PTEN,
mTOR, RICTOR, MAPKAP1 and DEPTOR, elevated expression
of PRDM14 (NCM- and RT-MEF), TCL1B (all naive hESC) and
AKT1 (NCM- and RT-MEF) in naive hESCs shows their
increased dependence on PI3K/AKT/mTORC pathway19,24,
speciﬁcally the mTORC2 subunit, as further validated by our
inhibitor assay. SNAI1, although an epithelial-to-mesenchymal
transition factor, is known to enhance reprogramming in human
and mouse somatic cells when overexpressed40. Interestingly, we
observed SNAI1 expression in naive hESCs increased, speciﬁcally
in NHSM-MEF, compared to primed hESCs (Fig. 6a). Naive
pluripotency markers including LEF1, KLF2, ZIC3, LEFTY2,
STAT3, HES1, SOCS3, MMP2, GBX2 were signiﬁcantly increased
(Po0.05) in all naive hESCs (Fig. 6b) whereas more primed
pluripotency-associated genes such as DUSP8, CACNA1A, HGF,
CER1, FGF2 continued to be signiﬁcantly downregulated8,10,21,41
(Fig. 6c). Naive hESCs, known to exist in a hypomethylated
state42, showed a similar expression of TET enzymes compared to
primed hESCs, however, all naive hESCs showed decreased levels
of de novo methyltransferase DNMT3A, DNMT3B compared to
primed hESCs whereas DNMT3L was signiﬁcantly increased,
similar to as observed in reset cells13 (Supplementary Data 6–8).
Comparison of the different naive conversion conditions with
each other (F-test, ANOVA, FDRo0.05) 4,195 genes were
differentially expressed (Supplementary Fig. 9, Supplementary
Data 12), such as naive markers including GBX2, KLF2, DPPA3,
SOAT1, PRDM14, TCL1B, SALL1 and differentiation-associated
genes such as GATA4, GATA6, AFP, SOX17, OTX2 between the
three naive culture conditions.
Overall, we report an unbiased molecular and transcriptional
analysis of naive hESCs generated in different culture conditions.
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Figure 4 | Directed differentiation of primed and naive hESCs towards
neuronal and cardiac lineages. (a) Representative images of primed,
NCM-, NHSM- and RT-MEF naive hESCs expressing b-TUBULIN when
differentiated towards neuronal lineage. b-TUBULIN is expressed higher in
neurons derived from primed and RT-MEF naive hESCs compared to
NCM- and NHSM-MEF naive hESCs. (b) Representative images of primed,
NCM-, NHSM- and RT-MEF naive hESCs expressing mature cardiac
markers TROPONIN and MYOSIN when differentiated towards
cardiomyocytes. Primed hESCs when differentiated towards cardiac lineage
expressing markers TROPONIN and MYOSIN whereas all naive hESCs fail
to express the mature markers. Scale bar, 200mm.
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Speciﬁcally, in-house-derived primed hESCs were converted in
the same laboratory, unlike previous studies that conducted
comparative analysis exclusively on published data sets. We also
demonstrate that although the naive hESCs can differentiate
efﬁciently towards immature cell types, the current differentiation
protocols shown to be working efﬁciently for primed hESCs,
probably require further optimization in order to be used for
naive hESCs, as these two pluripotency states reﬂect the different
stages of embryo development. Alternatively, it could be possible
that naive pluripotent stem cells require a priming towards a
more differentiated stage, before they acquire the full potential
of efﬁcient differentiation. Importantly, we conﬁrm the role of
PI3K/AKT/mTORC signalling in facilitating the induction of
naive pluripotency in not only primed hESCs converted in
NCM-MEF conditions, but also in NHSM- and RT-MEF naive
hESCs.
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Figure 5 | Genome-wide expression analysis of parental primed hESC and converted naive hESC in different conversion conditions. (a) PCA based
on normalized transciptome data. (b) PCA based on rlog values of the differentially expressed genes (FC4 2, FDRo0.05) between primed hESC and
all naive hESC. (c) Hierarchical clustering and heatmap of differentially expressed transcriptome data between parental primed and all naive hESCs.
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Figure 6 | Panel of genes of interest. (a) Genes involved in PI3K/AKT/mTORC pathway. (b) Genes related to naive pluripotency upregulated in
converted naive hESCS. (c) Genes related to lineage speciﬁcation downregulated in converted naive hESCs. The data are represented as mean±s.e.m.
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Methods
Culturing of primed hESCs. In-house-derived primed hESC lines UGent11-2
(XX), UGent11-60 (XX) and UGent11-70 (XY)8 were maintained on mitomycin C
treated-mitotically inactivated MEFs in low oxygen conditions (5%). The primed
cell cultures were fed every day with fresh hESC medium composed of knockout-
DMEM, 20% knockout serum replacement, 1% non-essential amino acids (NEAA),
1% l-glutamine, 1% penicillin/streptomycin, 0.1mM b-mercaptoethanol
(Invitrogen) and recombinant human basic ﬁbroblast growth factor (bFGF,
4 ngml 1, Peprotech). Conﬂuent cell cultures (usually 5 days) were passaged using
collagenase (1mgml 1, Invitrogen) and were split at a ratio of 1:2 to 1:4.
Conversion of primed hESCs to a naive state in different naive media. Three
primed hESC lines were subjected to naive conversion on MEFs in low oxygen
conditions in either: (i) naive human stem cell medium (NHSM) composed of
basal hESC media supplemented with AlbumaxI, N2 supplement (Invitrogen),
PD0325901 (1mM, Cayman) and CHIR99021 (3mM, Axon Medchem; known
together as 2i), leukaemia inhibitory factor (LIF, 1000U, Sigma), bFGF,
(8 ngml 1), SP600125 (10mM, Tocris), SB203580 (10mM, Tocris) and TGFb
(1 ngml 1, Peprotech)10; (ii) RT consisting of high glucose DMEM-F12
(Invitrogen) further supplemented with histone deacetylase inhibitors, sodium
butyrate (0.1mM) and SAHA (50 nM) for ﬁrst three passages followed by 2i and
bFGF (10 ngml 1)11 or (iii) our novel medium naive conversion medium (NCM)
containing hESC media with added 2i, LIF, forskolin (10mM, Sigma), ascorbic
acid (50 ngml 1, Sigma) and bFGF(12 ngml 1)8. Upon the appearance of
domed-shaped colonies, the culture was passaged using 0.05% trypsin and once the
culture was well established, cells were split at a ratio of 1:4 to 1:8 every 3 days.
Single-cell clonogenicity was determined from the number of single-cells plated
(upon dissociating primed and naive hESCs using trypsin without ROCKi) and the
subsequent number of colonies formed. Doubling time was calculated using the
formula:
Doubling time ¼durationlog 2ð Þ=logðfinal concentrationÞ
 logðinital concentrationÞ:
Immunocytochemistry. Undifferentiated naive hESCs in the different media were
ﬁxed using 4% paraformaldehyde at room temperature (rt) for 20min or at 4 C
overnight (O/N). The cells were then permeablized with 0.1% Triton X-100 in
1 phosphate buffered saline (PBS) for 8min, washed for 5min in 1 PBS and
blocked in 1% bovine serum albumin in 1 PBS for 1 h at rt. Primary antibodies,
anti-goat OCT4 (Santa Cruz Biotechnology), anti-rabbit NANOG (R&D Systems),
anti-rabbit PAX6 (Abcam), anti-mouse NKX2.5 (Abcam), anti-rabbit GATA4
(Santa Cruz Biotechnology), anti-mouse b-TUBULIN (Sigma-Aldrich), anti-rabbit
TROPONIN (Santa Cruz Biotechnology) and anti-mouse MYOSIN (Chemicon)
were diluted in the blocking solution (1:200) and the cells were then incubated with
primary antibodies at 4 C O/N. Next day, the cells were washed with 1 PBS
three times for 5min and were incubated with secondary antibodies (diluted in
blocking solution) for 1 h at rt. The secondary antibodies applied were donkey anti-
goat FITC (1:200, Bioconnect), donkey anti-mouse Alexa 488 (IgG H&L, Life
Technologies) and donkey anti-rabbit CY3 (1:200, Bioconnect). Finally, the cells
were rinsed again in 1 PBS three times for 5min and mounted onto glass slides
in Vectashield with 4’,6-diamidino-2-phenylindole (DAPI).
Differentiation assays. Spontaneous, directed, neuronal and cardiac differentia-
tion assays were carried out as previously described8,32,33 in low oxygen conditions.
In brief, for neuronal differentiation, cells were maintained on MEFs until they
reached B80% conﬂuency and were passaged to form EBs in 390ml DMEM/F12,
5ml NEAA, 5ml 100GlutaMAX, 36ml 2-mercaptoethanol and 100ml KOSR
(Invitrogen). On day 4, the media was changed to neural induction medium (NIM)
composed of 490ml DMEM/F12, 5ml NEAA, 5ml N2 supplement (Invitrogen)
and 20mgml 1 Heparin (Sigma). On day 7, EBs were plated in NIM containing
5% fetal bovine serum to promote attachment for 8 h and were refreshed gently
with fresh NIM once the EBs were attached. Neural rosettes were observed between
days 10–12. For cardiomyocyte differentiation, cells were plated as single cells in
the presence of ROCKi (Enzo Life) on matrigel (Corning). Differentiation was
initiated once the cells reached 80–90% conﬂuency and were cultured in RPMI/B27
(without insulin, Invitrogen) in the presence of CHIR9902 (12mM, Axon
MedChem) for 24 h. Next, the media was changed to only RPMI/B27 (without
insulin) and 72 h later, half the media was refreshed with additional
supplementation WNT inhibitor IWP2 (5 mM, Sigma) in the media. On day 5, the
cells were refreshed with fresh RPMI/B27 (without insulin) medium and day 7
onwards, the cells were refreshed with RPMI/B27 (with insulin). Spontaneous
contractions were observed between days 10–12. For spontaneous differentiation,
primed, as well as different, naive hESCs were trypsinized and re-suspended in
differentiation medium (DFM) similar to hESC medium without bFGF and the
knockout serum replacement replaced with fetal bovine serum and cultured as EBs
on 24-well Costar ultra-low attachment plates (Corning) for 14 days with medium
changed every other day. For lineage-speciﬁc differentiation, cells were either
exposed to DFM with 10mM retinoic acid for ectodermal differentiation for 10
days; to DFM supplemented with 5 ngml 1 bFGF and 10mM nicotinamide
(Sigma) for mesoderm formation for 8 days; or to DFM consisting of Activin A
(20 ngml 1, R&D Systems) and BMP4 (50 ngml 1, R&D Systems) for an
additional 7 days.
Quantitative real-time PCR. RNA isolation, cDNA synthesis, quantitative
real-time PCR (qRT-PCR) gene expression and data analysis was performed as
previously described8 for primed hESCs, EBs and naive hESCs and EBs. Brieﬂy,
RNA isolation and cDNA synthesis was performed using RNeasy Mini Kit
(Qiagen) and iSCRIPT Advanced cDNA synthesis Kit (Biorad), respectively, and
the cDNA concentration was determined using Qubit ﬂuorometric quantitation
method (Thermoﬁsher Scientiﬁc). For subsequent qRT-PCR gene expression
analysis, 10 ng cDNA was used for each reaction per gene, performed in technical
and biological replicates on an ABI 7000 sequence detection system (Applied
Biosystems). Housekeeping genes included GAPDH, B2M and RPL13A, naive
pluripotency markers used were KLF2, KLF4, ESRRB, PRDM14, REX1, TCL1B,
OCT4 and NANOG. Germ layer-speciﬁc markers used were NESTIN and PAX6
(ectoderm), T-BRACHYURY, HAND1 and PECAM1 (mesoderm), AFP, GATA4
and GATA6 (endoderm). CT values were normalized to housekeeping genes and
fold change was analysed using the DDCT method where all samples were
compared to their respective controls in each experiment. Statistical signiﬁcance
was calculated using the ANOVA and t-test on fold change gene expression values
(2DDCT). No RT (only RNA) or no template (water) were used as negative
controls.
Array-based comparative genome hybridization. Whole-genome ampliﬁcation
of the samples was performed using the SurePlex Ampliﬁcation system following
manufacturer’s instructions (Illumina Bluegnome, United Kingdom). A total of
2.5 ml of control DNA (G1521; Promega; 187 ng ml 1) was used at a concentration
of 25 pg ml 1. Whole-genome ampliﬁcation products were hybridized on 24sureþ
arrays (Illumina Bluegnome, UK) according to manufacturer’s instructions. A male
reference sample was used for all tested samples. Brieﬂy, ampliﬁed samples (from
one colony/naive condition at passage 48) and reference DNA were labelled with
Cy3 and Cy5 ﬂuorophores, respectively, for 4 h at 37 C. After combining sample
and reference with Cot1 DNA, the mixture was precipitated for 20min at  80 C.
The pellets were re-suspended in pre-warmed hybridization buffer and hybridized
on a 24sureþ array for 16 h (overnight) at 42 C. After washing, microarrays were
scanned on an Agilent G2565CA microarray scanner (Agilent, USA). Data were
analysed using the BlueFuse Multi software (Illumina Bluegnome, United King-
dom) and visualized in the Vivar software.
RNA-seq method and data analysis. Total RNA was extracted using Qiagen
RNeasy mini kit, according to the manufacturers’ protocol, including a DNAse
digestion. Concentration and quality of the total extracted RNA was checked by
using the ‘Quant-it ribogreen RNA assay’ (Life Technologies, Grand Island, NY,
USA) and the RNA 6000 nano chip (Agilent Technologies, Santa Clara, CA, USA),
respectively. Subsequently, 500 ng of RNA was used to perform an Illumina
sequencing library preparation using the QuantSeq 3’ mRNA-Seq Library Prep Kits
(Lexogen, Vienna, Austria) according to manufacturer’s protocol. Libraries were
quantiﬁed by qPCR, according to Illumina’s protocol ‘Sequencing Library qPCR
Quantiﬁcation protocol guide’, version February 2011. A High sensitivity DNA
chip (Agilent Technologies, Santa Clara, CA, USA) was used to control the library’s
size distribution and quality. Sequencing was performed on a high throughput
Illumina NextSeq 500 ﬂow cell generating 75 bp single reads.
Per sample, on average 5.8 106±1.5 106 reads were generated. First, these
reads were trimmed using cutadapt43 version 1.11 to remove the ‘QuantSEQ FWD’
adaptor sequence. To remove contamination with mouse DNA, the reads were
mapped against the Mus musculus GRCm38.p5 reference genome using CLC
genomics workbench version 9.0.1 (CLC). Only the reads that didn’t map against
the GRCm38.p5 genome were subsequently mapped against the Homo sapiens
hg19 GRCH37.74 genome using CLC. Count tables were made by counting the
reads that mapped against the genes deﬁned by the Ensembl GRCh37.74 Gene
transfer format ﬁle and exported from CLC.
To explore if the samples from different treatment groups clustered together
and to detect outlier samples, a PCA was performed in R on the rlog44 normalized
and transformed counts of the genes expressed at c.p.m. above 1 in at least two
samples.
Differential gene expression analysis was performed using edgeR45. Genes were
only retained if they were expressed at a c.p.m. above 1 in at least two samples. In
one differential gene expression analysis, a general linear model was made with two
treatments ‘primed’ versus ‘non-primed’ (including the ‘NCM’, ‘NHSM’ and ‘RT’
samples), deﬁning the effects from the three cell lines ‘UGent11-60’, ‘UGent11-2’
and ‘UGent11-70’ as batch effect. Statistical testing was done using the empirical
Bayes quasi-likelihood F-test. Genes having a FDRo0.05 and a fold change42
were considered signiﬁcantly differential. PCA was performed in R on rlog44
transformed c.p.m. of the differentially expressed genes. To produce the heat map,
the normalized count data of the differentially expressed genes was rescaled
between  3 and 3 and clustered based on Pearson correlation46. In an alternative
differential gene expression analysis, a general linear model was made with four
treatments ‘primed’, ‘NCM’, ‘NHSM’ and ‘RT’, deﬁning the effects from the three
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cell lines ‘UGent11-60’, ‘UGent11-2’ and ‘UGent11-70’ as batch effect. The latter
model was used to statistically compare ‘primed’ versus ‘NCM’, ‘primed’ versus
‘NHSM’ and ‘primed’ versus ‘RT’. Statistical testing was done using the Bayes
quasi-likelihood F-test. Genes with an FDRo0.05 and a fold change42 were
considered signiﬁcantly differential. To compare the three ‘non-primed’
treatments, a general linear model was made with three treatments ‘NCM’, ‘NHSM’
and ‘RT’, deﬁning the effects from the three cell lines ‘UGent11-60’, ‘UGent11-2’
and ‘UGent11-70’ as batch effect. The latter model was used to statistically test any
difference between the three ‘non-primed’ treatments using empirical Bayes quasi-
likelihood F-test. Genes with a FDRo0.05 were considered signiﬁcantly
differential. PCA was performed in R on rlog44 transformed c.p.m. of the
differentially expressed genes. To produce the heat map, the normalized count data
of the differentially expressed genes was rescaled between  3 and 3 and clustered
based on Pearson correlation46.
Differential expression of pathways in the gene set data collection ‘kegg.gs’
derived from the KEGG database, was based on log fold changes of the pairwise
comparison of ‘primed’ versus ‘NCM’, ‘primed’ versus ‘NHSM’ and ‘primed’ versus
‘RT’ using the GAGE R package47. Pathways were considered differentially
expressed when the average log fold change of the pathway was signiﬁcantly
different from the overall average log fold change at an FDRo0.05. Differentially
expressed pathways were visualized using Pathview48, showing the log fold change
for each comparison and each enzyme in the pathway. Analogously, a differentially
expression analysis was performed on the biological and the molecular function
GO-terms and the chemical and genetic perturbations gene set from the Molecular
Signatures Database49. Gene sets were considered differentially expressed when the
average log fold change of the gene set was signiﬁcantly different from the overall
average log fold change at an FDRo0.05.
Data availability. The authors declare that all supporting data are submitted
under BioSample accession numbers SAMN06111297, SAMN06111298,
SAMN06111299, SAMN06111300, SAMN06111301, SAMN06111302,
SAMN06111303, SAMN06111304, SAMN06111305, SAMN06111306,
SAMN06111307, SAMN06111308 and also supplied as Supplementary Datasets.
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